Glipizide 2.5 MG / metformin hydrochloride 250 MG Oral Tablet — RxCUI 861731
RxNorm drug concept · Semantic clinical drug
RxCUI 861731
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861731
Official nameGlipizide 2.5 MG / metformin hydrochloride 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglipiZIDE 2.5 MG / metFORMIN HCl 250 MG Oral Tablet
FDA products mapped15
Package NDCs mapped36
Reported Medicaid activity (SDUD)28,289 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Glipizide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Glipizide is used to help lower blood sugar in adults with type 2 diabetes. It works by telling your pancreas to release more insulin after you eat. It's meant to be used alongside...
- What exactly is glipizide for, and how does it help my diabetes?
- Timing really does matter with this one. If you're taking the regular tablet, aim to take it about 30 minutes before a meal — that way it's working right when your blood sugar star...
- When should I take my glipizide, and does it matter if I eat?
🕸️ Concept Web — How Glipizide 2.5 MG / metformin hydrochloride 250 M... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Glipizide 2.5 MG / metformin hydrochloride 250 MG Oral Tablet
RxCUI 861731 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Glipizide
4821IN -
Metformin
6809IN -
Glipizide / metformin
352381MIN -
Metformin hydrochloride
235743PIN
-
Glipizide
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glipizide / metformin Oral Tablet
378730SCDF -
Glipizide / metformin hydrochloride Oral Tablet
2646330SCDFP -
Glipizide / metformin Oral Product
1165205SCDG -
Glipizide / metformin Pill
1165206SCDG -
Glipizide / metformin hydrochloride Oral Product
2660588SCDGP -
Glipizide / metformin hydrochloride Pill
2661987SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Glipizide / metformin Oral Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glipizide 2.5 MG
330349SCDC -
Metformin hydrochloride 250 MG
861730SCDC
-
Glipizide 2.5 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glipizide 2.5 MG
SCDC · 330349 -
Metformin hydrochloride 250 MG
SCDC · 861730 -
Glipizide / metformin Oral Tablet
SCDF · 378730 -
Glipizide / metformin hydrochloride Oral Tablet
SCDFP · 2646330 -
Glipizide / metformin Oral Product
SCDG · 1165205 -
Glipizide / metformin Pill
SCDG · 1165206 -
Glipizide / metformin hydrochloride Oral Product
SCDGP · 2660588 -
Glipizide / metformin hydrochloride Pill
SCDGP · 2661987
📦 FDA Products & Package NDCs
15 products · 36 package NDCs
36 package NDCs map to RxCUI 861731 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-7455-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-7455-01) | Glipizide and Metformin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2005-10-28 |
| 00093-7456-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-7456-01) | Glipizide and Metformin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2005-10-28 |
| 00093-7457-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-7457-01) | Glipizide and Metformin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2005-10-28 |
| 23155-0115-01 | 100 TABLET, FILM COATED in 1 BOTTLE (23155-115-01) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 23155-0115-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-115-10) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 23155-0116-01 | 100 TABLET, FILM COATED in 1 BOTTLE (23155-116-01) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 23155-0116-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-116-10) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 23155-0117-01 | 100 TABLET, FILM COATED in 1 BOTTLE (23155-117-01) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 23155-0117-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-117-10) | Glipizide and Metformin HCl | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2010-06-29 |
| 62135-0731-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-731-60) | Glipizide and metformin hcl | Chartwell RX, LLC | 2023-08-15 |
| 62135-0732-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-732-60) | Glipizide and metformin hcl | Chartwell RX, LLC | 2023-08-15 |
| 62135-0733-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-733-60) | Glipizide and metformin hcl | Chartwell RX, LLC | 2023-08-15 |
| 65841-0659-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-659-01) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0659-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (65841-659-10) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0659-16 | 90 TABLET, FILM COATED in 1 BOTTLE (65841-659-16) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0659-77 | 10 BLISTER PACK in 1 CARTON (65841-659-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0660-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-660-01) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0660-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (65841-660-10) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0660-16 | 90 TABLET, FILM COATED in 1 BOTTLE (65841-660-16) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0660-77 | 10 BLISTER PACK in 1 CARTON (65841-660-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0661-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-661-01) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0661-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (65841-661-10) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0661-16 | 90 TABLET, FILM COATED in 1 BOTTLE (65841-661-16) | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 65841-0661-77 | 10 BLISTER PACK in 1 CARTON (65841-661-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Lifesciences Limited | 2016-05-05 |
| 68382-0184-01 | 100 TABLET, FILM COATED in 1 BOTTLE (68382-184-01) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0184-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68382-184-10) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0184-16 | 90 TABLET, FILM COATED in 1 BOTTLE (68382-184-16) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0184-77 | 10 BLISTER PACK in 1 CARTON (68382-184-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0185-01 | 100 TABLET, FILM COATED in 1 BOTTLE (68382-185-01) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0185-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68382-185-10) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0185-16 | 90 TABLET, FILM COATED in 1 BOTTLE (68382-185-16) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0185-77 | 10 BLISTER PACK in 1 CARTON (68382-185-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0186-01 | 100 TABLET, FILM COATED in 1 BOTTLE (68382-186-01) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0186-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68382-186-10) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0186-16 | 90 TABLET, FILM COATED in 1 BOTTLE (68382-186-16) | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
| 68382-0186-77 | 10 BLISTER PACK in 1 CARTON (68382-186-77) / 10 TABLET, FIL... | Glipizide and Metformin Hydrochloride | Zydus Pharmaceuticals USA Inc. | 2016-05-05 |
Observed labelers:
Zydus Lifesciences Limited (12) ·
Zydus Pharmaceuticals USA Inc. (12) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (6) ·
Chartwell RX, LLC (3) ·
Teva Pharmaceuticals USA, Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.